These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 10548489)
61. Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells. Kanazawa Y; Ohkawa K; Ueda K; Mita E; Takehara T; Sasaki Y; Kasahara A; Hayashi N Biochem Biophys Res Commun; 1996 Aug; 225(2):570-6. PubMed ID: 8753802 [TBL] [Abstract][Full Text] [Related]
62. Detection of telomerase inhibitors based on g-quadruplex ligands by a modified telomeric repeat amplification protocol assay. Gomez D; Mergny JL; Riou JF Cancer Res; 2002 Jun; 62(12):3365-8. PubMed ID: 12067975 [TBL] [Abstract][Full Text] [Related]
63. Detection of telomerase activity in Chinese hamster V79 cells and its inhibition by 7-deaza-deoxy guanosine triphosphate and (TTAGGG)4 in vitro. Pandit B; Bhattacharyya NP Biochem Biophys Res Commun; 1998 Oct; 251(2):620-4. PubMed ID: 9792823 [TBL] [Abstract][Full Text] [Related]
64. Effect of DNA secondary structure on human telomerase activity. Fletcher TM; Sun D; Salazar M; Hurley LH Biochemistry; 1998 Apr; 37(16):5536-41. PubMed ID: 9548937 [TBL] [Abstract][Full Text] [Related]
65. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease. Tárkányi I; Aradi J Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408 [TBL] [Abstract][Full Text] [Related]
66. Enzymatic activity of endogenous telomerase associated with intact nuclei from human leukemia CEM cells. Fletcher TM; Trevino A; Woynarowski JM Biochem Biophys Res Commun; 1999 Nov; 265(1):51-6. PubMed ID: 10548489 [TBL] [Abstract][Full Text] [Related]